Treatment Guides

Enlarged Prostate (BPH) & PSA Screening in Singapore: Symptoms, Treatment & Cost

Written by · Last updated

a computer generated image of a red and blue object
Share this article

Quick answer. Benign prostatic hyperplasia (BPH) is a common, non-cancerous enlargement of the prostate that develops with age and causes lower urinary tract symptoms such as a weak stream, frequency, urgency and waking at night to pass urine. Treatment follows a ladder: lifestyle measures and medication (alpha-blockers like tamsulosin and 5-alpha-reductase inhibitors like dutasteride) first, then minimally invasive or surgical options such as TURP, laser (HoLEP/GreenLight), UroLift and Rezum, most of which are day-surgery and MediSave-claimable. Prostate cancer screening using the PSA blood test is separate and is a shared decision with your doctor, because PSA is not a definitive test and can give false positives; it is typically considered for men around age 50+ (or earlier with a family history). In Singapore, a PSA test costs roughly S$30-60, while TURP runs from around S$2,000-3,800 in public subsidised wards to S$16,000-25,000 in private hospitals before MediSave and insurance.

Bothered by urinary, prostate or men’s-health concerns?

Message our care team on WhatsApp. Tell us what’s going on and we’ll help you find the right best urology clinic — free, with no obligation.

Chat with our care team on WhatsApp

Not sure who to see? Find the right specialist →

In a medical emergency, or for severe or sudden symptoms such as breathing difficulty, chest pain, fainting or stroke signs, call 995 immediately.

An enlarged prostate is one of the most common reasons men over 50 in Singapore see a urologist. The good news is that it is usually benign prostatic hyperplasia (BPH) – a non-cancerous condition – and there is a wide range of effective treatments, from simple tablets to quick day-surgery procedures. This guide explains the symptoms and red flags, how BPH is diagnosed, the treatment ladder, and the separate question of prostate cancer (PSA) screening, along with typical Singapore cost ranges. It is general information, not a substitute for assessment by a qualified doctor.

At a glance

Typical BPH / prostate screening items and indicative Singapore cost ranges (2026, before MediSave and insurance)
Treatment / item What it is Typical cost
PSA blood test Blood test that may raise suspicion of prostate cancer; not definitive ~S$30-60
Specialist consultation Urologist assessment (private; subsidised rates lower) ~S$120-250+
BPH medication Alpha-blockers (tamsulosin) and/or 5-ARIs (finasteride, dutasteride) Affordable monthly outpatient cost; lower if subsidised
TURP (public, subsidised) Gold-standard operation to remove obstructing tissue, B2/C ward ~S$2,000-3,800
TURP (private) Same procedure in a private hospital ~S$16,000-25,000
Laser (HoLEP / GreenLight) Laser enucleation/vaporisation of prostate tissue; MediSave-claimable Varies by setting; day surgery/short stay
UroLift / Rezum Minimally invasive day-surgery options; MediSave-claimable Varies by clinic; ask for a quote

What is BPH and what are the symptoms?

The prostate is a small gland below the bladder that surrounds the urethra (the tube urine flows through). As men age, the prostate commonly enlarges – this is benign prostatic hyperplasia (BPH). It is not cancer, and having BPH does not turn into or cause prostate cancer. However, the enlarged gland can press on the urethra and cause lower urinary tract symptoms (LUTS):

  • Weak or slow urinary stream
  • Difficulty starting urination (hesitancy) or straining
  • Frequent urination, including waking at night (nocturia)
  • Sudden urge to urinate (urgency)
  • Feeling the bladder is not fully emptied, or dribbling at the end

Symptoms often build up gradually over years. Many men have mild symptoms that simply need monitoring, while others find their quality of life and sleep significantly affected.

When to see a doctor and red-flag warning signs

See a doctor if urinary symptoms are bothersome, affecting your sleep or daily life, or getting worse. Seek urgent medical attention if you experience any of these red flags, which can signal complications or another condition:

  • Blood in the urine (haematuria)
  • Acute urinary retention – a sudden, painful inability to pass urine at all (a medical emergency)
  • Recurrent urinary tract infections
  • Burning or pain on urination, fever, or lower abdominal/back pain
  • Bladder stones or evidence of kidney involvement

These symptoms do not necessarily mean cancer, but they need prompt assessment. Untreated severe BPH can occasionally lead to bladder stones, infections or kidney problems, which is why a check-up is worthwhile rather than self-treating.

How BPH is diagnosed

A urologist or GP will usually combine several simple assessments:

  • History and IPSS symptom score – the International Prostate Symptom Score is a short questionnaire that rates how severe and bothersome your symptoms are.
  • Digital rectal examination (DRE) – the doctor feels the prostate through the rectum to estimate its size and check for irregularities.
  • Urine tests – to look for infection or blood.
  • PSA blood test – may be done to help assess the prostate; note that PSA can be raised by BPH itself, not just cancer (see the screening section below).
  • Uroflowmetry – measures the speed and pattern of your urine flow.
  • Ultrasound – checks prostate size and how completely the bladder empties (post-void residual volume).

These help distinguish BPH from other causes and guide which treatment is appropriate.

BPH treatment ladder: lifestyle, medication, surgery

Treatment is matched to how much the symptoms bother you and how large the prostate is. It generally follows a ladder:

1. Watchful waiting and lifestyle – for mild symptoms, your doctor may simply monitor you. Helpful measures include cutting down on caffeine and alcohol, not drinking large amounts in the evening, and double-voiding (emptying the bladder twice).

2. Medication – the usual first-line drug treatment:

  • Alpha-blockers (e.g. tamsulosin) relax the muscle around the prostate and bladder neck to improve flow, often within days to weeks.
  • 5-alpha-reductase inhibitors (e.g. finasteride, dutasteride) gradually shrink the prostate over several months and suit larger glands. They are sometimes combined with an alpha-blocker for moderate-to-severe symptoms.

3. Minimally invasive and surgical procedures – considered when medication is insufficient or not tolerated, or for complications such as retention or bladder stones:

  • TURP (transurethral resection of the prostate) – the long-standing gold-standard operation that removes obstructing tissue; usually a short hospital stay.
  • Laser surgery (HoLEP, GreenLight) – uses laser to enucleate or vaporise prostate tissue, often with less bleeding and a shorter stay.
  • UroLift – tiny implants hold the prostate tissue open; a quick day-surgery procedure that aims to preserve sexual function and uses no cutting or heat.
  • Rezum – water-vapour (steam) therapy delivered in a short day procedure to shrink prostate tissue over the following weeks.

Most of these procedures are performed as day surgery or short stays and are MediSave-claimable, with Integrated Shield Plans commonly providing further coverage. Your urologist will advise which option fits your prostate size, symptoms and priorities (such as preserving ejaculation).

Prostate cancer and PSA screening: a shared decision

This is a separate issue from BPH. The PSA (prostate-specific antigen) test is a blood test that can raise suspicion of prostate cancer, but it is not a definitive test. PSA can be elevated by non-cancerous conditions including BPH, prostate inflammation, infection or recent activity – so a raised PSA does not mean you have cancer, and it is always interpreted alongside the DRE and clinical findings, sometimes followed by MRI or biopsy.

Because PSA screening can produce false positives and can detect slow-growing cancers that may never have caused harm (overdiagnosis), Singapore does not recommend routine population-wide PSA screening. Instead, it is a shared decision you make with your doctor after discussing the pros and cons. Screening is typically considered for men around age 50 and above, or from the mid-40s for those at higher risk – for example, a family history of prostate or breast cancer. Importantly, BPH is not cancer and does not become cancer; a man can have BPH, prostate cancer, both, or neither.

Typical costs in Singapore

Costs vary widely between public (subsidised) and private settings, the procedure chosen, and your insurance. As a guide based on published Singapore sources:

  • PSA blood test: roughly S$30-60 at private screening providers.
  • Specialist consultation: private urology consultations are commonly in the region of S$120-250+; subsidised polyclinic/restructured-hospital rates are lower.
  • Prostate ultrasound: around S$200-250 at private providers.
  • BPH medication: generic alpha-blockers and 5-ARIs are relatively affordable as a monthly outpatient cost, especially at subsidised pharmacies.
  • TURP: from about S$2,000-3,800 in subsidised public wards (B2/C) up to roughly S$16,000-25,000 in private hospitals, before MediSave and insurance.

Surgical and minimally invasive BPH procedures are MediSave-claimable and frequently covered in part by MediShield Life / Integrated Shield Plans, which can substantially reduce out-of-pocket cost. Always ask the clinic for a written quotation and check your coverage in advance.

Related guides

Sources

Last updated 21 June 2026. Prices are typical market ranges gathered from the cited sources and vary by clinic, doctor and individual case — they are not quotes. This guide is general information, not medical advice; always consult a qualified, MOH-accredited doctor before any treatment.

Related conditions & guides

Related conditions and guides you may find useful:

Frequently asked questions

Does having BPH mean I will get prostate cancer?

No. BPH (benign prostatic hyperplasia) is a non-cancerous enlargement of the prostate and does not turn into or cause prostate cancer. They are separate conditions, though a man can have both. BPH can, however, raise your PSA level, which is one reason a raised PSA is not automatically a sign of cancer.

Is a high PSA a definite sign of prostate cancer?

No. PSA is a screening blood test, not a diagnosis. It can be elevated by benign conditions such as BPH, prostate inflammation or infection, and it can also miss some cancers. A raised PSA usually prompts further assessment such as a rectal examination, an MRI scan or sometimes a biopsy before any conclusion is reached.

At what age should I consider PSA screening?

In Singapore, PSA screening is a shared decision to make with your doctor rather than a routine test for everyone. It is typically considered for men from around age 50, or from the mid-40s for those at higher risk such as a family history of prostate or breast cancer. Your doctor will discuss the benefits and limitations, including false positives and overdiagnosis.

Can I claim BPH surgery under MediSave?

Yes. Surgical and minimally invasive BPH procedures such as TURP, laser surgery, UroLift and Rezum are MediSave-claimable, and MediShield Life or Integrated Shield Plans often cover part of the cost. Many of these are done as day surgery or short hospital stays. Check the exact claim limits and your coverage with the clinic and your insurer beforehand.

Do I always need surgery for an enlarged prostate?

No. Many men are managed with lifestyle changes and/or medication (alpha-blockers and 5-alpha-reductase inhibitors). Procedures are considered when symptoms remain bothersome despite medication, medication is not tolerated, or there are complications such as urinary retention, bladder stones or recurrent infections.